Pharmaceutical Preparations
Standard Industrial Classification: SIC 2834
Industry Insider Sentiment Analysis
The Pharmaceutical Preparations sector (SIC 2834) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-18 23:48 | 2025-03-17 | ZOM | Zomedica Corp. | MACLEOD CHRISTOPHER ROSS | Director | BUY | $0.06 | 143,000 | $8,437 | 143,000 |
| 2025-03-18 23:36 | 2025-03-17 | ZOM | Zomedica Corp. | Klass Russell Kevin | Officer | BUY | $0.07 | 699,980 | $48,999 | 3,200,030 |
| 2025-03-18 23:24 | 2025-03-17 | ZOM | Zomedica Corp. | Williams Rodney James | Director | BUY | $0.07 | 100,000 | $6,900 | 100,000 |
| 2025-03-18 23:27 | 2025-03-14 | PRLD | Prelude Therapeutics Inc | Vaddi Krishna | Director, Officer | BUY | $0.75 | 39,105 | $29,462 | 1,303,880 |
| 2025-03-19 01:45 | 2025-03-17 | VRCA | Verrica Pharmaceuticals Inc. | Hayes Christopher G. | Officer | SELL | $0.65 | 4,315 | $2,805 | 176,458 |
| 2025-03-18 23:51 | 2025-03-14 | BGNE | BeOne Medicines Ltd. | Wu Xiaobin | Officer | SELL | $0.00 | 0 | $0 | 0 |
| 2025-03-19 04:30 | 2025-03-17 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | Officer | OPT+S | $44.21 | 7,879 | $348,364 | 18,672 |
| 2025-03-19 04:16 | 2025-03-14 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | Officer | OPT+S | $51.48 | 75,000 | $3,861,270 | 40,370 |
| 2025-03-18 23:52 | 2025-03-17 | ZOM | Zomedica Corp. | Rowe Jeffrey M | Director | BUY | $0.07 | 1,439,005 | $96,126 | 1,714,005 |
| 2025-03-19 04:30 | 2025-03-17 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | Director, Officer | OPT+S | $44.21 | 27,279 | $1,206,122 | 138,641 |
| 2025-03-19 03:07 | 2025-03-14 | LYEL | Lyell Immunopharma, Inc. | Klausner Richard | Director | BUY | $0.60 | 158,000 | $94,942 | 843,365 |
| 2025-03-19 00:00 | 2025-03-14 | ABBV | AbbVie Inc. | Reents Scott T | Officer | SELL | $212.34 | 17,644 | $3,746,527 | 11,577 |
| 2025-03-18 19:27 | 2025-03-17 | APLS | Apellis Pharmaceuticals Inc. | Chopas James George | Officer | SELL | $24.82 | 183 | $4,543 | 47,955 |
| 2025-03-19 00:04 | 2025-03-14 | MIRM | Mirum Pharmaceuticals, Inc. | Heron Patrick J | Director | BUY | $44.11 | 549 | $24,214 | 168,672 |
| 2025-03-19 01:59 | 2025-03-14 | LYEL | Lyell Immunopharma, Inc. | Seely Lynn | Director, Officer | BUY | $0.61 | 175,000 | $106,190 | 712,500 |
| 2025-03-18 23:15 | 2025-03-17 | ALT | Altimmune, Inc. | Sohn Catherine A. | Director | BUY | $5.78 | 1,000 | $5,785 | 1,000 |
| 2025-03-18 23:38 | 2025-03-17 | ZOM | Zomedica Corp. | Blair Anthony K | Officer | BUY | $0.06 | 500,000 | $30,000 | 900,000 |
| 2025-03-19 00:35 | 2025-03-14 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Tupper Colleen | Officer | SELL | $30.00 | 977 | $29,313 | 164,269 |
| 2025-03-19 00:34 | 2025-03-14 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | Officer | SELL | $30.00 | 2,255 | $67,661 | 124,421 |
| 2025-03-19 02:18 | 2025-03-11 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | Officer | SELL | $30.00 | 15,387 | $461,672 | 126,676 |
| 2025-03-18 23:40 | 2025-03-17 | ZOM | Zomedica Corp. | HEATON LARRY C II | Director, Officer | BUY | $0.06 | 500,000 | $29,700 | 1,000,000 |
| 2025-03-19 02:12 | 2025-03-18 | ALZN | Alzamend Neuro Inc. | AULT MILTON C III | Director, 10% owner | BUY | $0.96 | 5,000 | $4,810 | 82,368 |
| 2025-03-18 23:42 | 2025-03-17 | ZOM | Zomedica Corp. | POWERS JOHNNY D | Director | BUY | $0.07 | 500,000 | $33,650 | 2,925,000 |
| 2025-03-19 02:08 | 2025-03-17 | CYRX | Cryoport, Inc. | ZECCHINI EDWARD J | Officer | SELL | $6.29 | 1,140 | $7,173 | 66,911 |
| 2025-03-19 02:07 | 2025-03-17 | CYRX | Cryoport, Inc. | STEFANOVICH ROBERT | Officer | SELL | $6.29 | 1,659 | $10,438 | 191,419 |
| 2025-03-19 02:06 | 2025-03-17 | CYRX | Cryoport, Inc. | Sawicki Mark W | Officer | SELL | $6.29 | 2,092 | $13,162 | 85,436 |
| 2025-03-19 02:05 | 2025-03-17 | CYRX | Cryoport, Inc. | SHELTON JERRELL | Director, Officer | SELL | $6.29 | 4,620 | $29,068 | 765,399 |
| 2025-03-19 00:20 | 2025-03-14 | PTCT | PTC THERAPEUTICS, INC. | Pauwels Eric | Officer | SELL | $56.16 | 11,220 | $630,104 | 72,640 |
| 2025-03-18 23:29 | 2025-03-18 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | Officer | OPT+S | $43.58 | 2,000 | $87,160 | 140,455 |
| 2025-03-18 00:00 | 2025-03-14 | RAPP | Rapport Therapeutics, Inc. | Bredt David | Officer | SELL | $10.85 | 8,500 | $92,205 | 469,142 |
| 2025-03-17 23:27 | 2025-03-13 | PHAT | Phathom Pharmaceuticals, Inc. | Parikh Asit | Director | BUY | $4.42 | 10,000 | $44,200 | 85,500 |
| 2025-03-17 23:51 | 2025-03-13 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer | OPT+S | $14.99 | 61,403 | $920,511 | 121,936 |
| 2025-03-17 23:51 | 2025-03-14 | AMRX | Amneal Pharmaceuticals Inc. | Patel Tushar Bhikhubhai | 10% owner | SELL | $8.35 | 5,000,000 | $41,750,000 | 48,578,209 |
| 2025-03-18 04:05 | 2025-03-13 | MLYS | Mineralys Therapeutics, Inc. | Samsara BioCapital GP, LLC | 10% owner | BUY | $13.50 | 600,000 | $8,100,000 | 5,674,916 |
| 2025-03-17 23:09 | 2025-03-13 | VRTX | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | Officer | SELL | $510.00 | 3,231 | $1,647,810 | 23,281 |
| 2025-03-18 00:45 | 2025-03-13 | ARWR | Arrowhead Pharmaceuticals Inc. | Anzalone Christopher Richard | Director, Officer | SELL | $15.07 | 51,425 | $774,975 | 4,062,377 |
| 2025-03-18 00:14 | 2025-03-13 | NGNE | Neurogene Inc. | Cvijic Christine Mikail | Officer | SELL | $16.94 | 4,501 | $76,247 | 72,343 |
| 2025-03-18 00:27 | 2025-03-17 | OPK | OPKO HEALTH, INC. | FROST PHILLIP MD ET AL | Director, Officer, 10% owner | BUY | $1.74 | 200,000 | $347,820 | 213,501,448 |
| 2025-03-18 02:56 | 2025-03-13 | MLYS | Mineralys Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | BUY | $13.50 | 1,296,296 | $17,499,996 | 4,280,051 |
| 2025-03-18 04:04 | 2025-03-13 | MLYS | Mineralys Therapeutics, Inc. | AKKARAJU SRINIVAS | Director | BUY | $13.50 | 600,000 | $8,100,000 | 5,674,916 |
| 2025-03-17 23:01 | 2025-03-13 | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Director, Officer | SELL | $12.06 | 4,000 | $48,220 | 2,831,260 |
| 2025-03-18 00:20 | 2025-03-13 | PTCT | PTC THERAPEUTICS, INC. | Okey Stephanie | Director | SELL | $54.00 | 5,000 | $270,000 | 8,867 |
| 2025-03-18 03:23 | 2025-03-17 | CYTK | CYTOKINETICS INC | Callos Andrew | Officer | SELL | $44.38 | 2,775 | $123,155 | 34,888 |
| 2025-03-18 03:21 | 2025-03-17 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | Officer | SELL | $44.38 | 4,389 | $194,784 | 101,005 |
| 2025-03-18 03:19 | 2025-03-17 | CYTK | CYTOKINETICS INC | Blum Robert I | Director, Officer | SELL | $44.38 | 12,648 | $561,318 | 326,533 |
| 2025-03-17 23:36 | 2025-03-17 | CYTK | CYTOKINETICS INC | Blum Robert I | Director, Officer | SELL | $44.65 | 25,000 | $1,116,250 | 339,181 |
| 2025-03-17 23:33 | 2025-03-17 | CYTK | CYTOKINETICS INC | Callos Andrew | Officer | OPT+S | $45.14 | 20,900 | $943,426 | 37,663 |
| 2025-03-14 23:30 | 2025-03-12 | RPTX | Repare Therapeutics Inc. | Koehler Maria | Officer | SELL | $1.14 | 3,596 | $4,099 | 227,813 |
| 2025-03-14 23:30 | 2025-03-12 | RPTX | Repare Therapeutics Inc. | Zinda Michael | Officer | SELL | $1.14 | 5,611 | $6,397 | 80,297 |
| 2025-03-14 23:30 | 2025-03-12 | RPTX | Repare Therapeutics Inc. | Forte Steve | Officer | SELL | $1.14 | 6,884 | $7,848 | 54,786 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Pharmaceutical Preparations sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2834) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Pharmaceutical Preparations
Every transaction in the Pharmaceutical Preparations industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.